Focused on People
Founded and headquartered in Shanghai, JI (Shanghai) Biotech Co., Ltd. is a privately held oncology company. We are facilitating the development of oncology drugs in China with Arog Pharmaceuticals, Inc, a U.S. based biotech who obtained global rights to crenolanib from Pfizer in 2010. JI (Shanghai) Biotech plans on participating in Arog’s global development plan by conducting local arms of its Ph. III studies in AML and, potentially, solid tumors.
Authors: Aaron D. Goldberg, Catherine C. Coombs, Eunice S. Wang, Roland B. Walter, Chatchada Karanes, Carlos E. Vigil, Boo Messahel, Richard M. Stone, Robert H. Collins
Authors: Richard M. Stone, Martha Wadleigh, Ilene Galinksy, Boo Messahel
Authors: Robert Collins, Swaminathan Padmanabhan Iyer, Yogesh S Jethava, Chatchada Karanes, Boo Messahel
Discover Our Trials
Learn more about current trials available with JI (Shanghai) Biotech